The Northern-European Initiative on Colorectal Cancer
NordICC The Northern-European Initiative on Colorectal Cancer
Sponsor: Erasmus Medical Center
A PHASE3 clinical study on Colorectal Cancer, this trial is ongoing. The trial is conducted by Erasmus Medical Center and has accumulated 8 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Jan 2022 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Aug 2017 — May 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Aug 2017 [monthly]
Recruiting PHASE3
First recorded
May 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Erasmus Medical Center
- Harvard School of Public Health (HSPH)
- Karolinska Institutet
- Landspitali University Hospital
- Maria Sklodowska-Curie National Research Institute of Oncology
- Memorial Sloan Kettering Cancer Center
- Oslo University Hospital
- Uppsala University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Boston, United States
- • New York, United States
- • Oslo, Norway
- • Reykjavik, Iceland
- • Rotterdam, Netherlands
- • Stockholm, Sweden
- • Warsaw, Poland